Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: multicenter echo-Doppler

Eui-Young Choi1, Se-Joong Rim, Jong-Won Ha

  • 1Yonsei University College of Medicine, Seoul, Republic of Korea.

Cardiology
|October 16, 2007
PubMed

Insights

Apical hypertrophic cardiomyopathy (ApHCM) presents three distinct subtypes: pure focal, pure diffuse, and mixed. Subtyping ApHCM is crucial for predicting atrial fibrillation risk and assessing left ventricular function.

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Genetics

Background:

  • Apical hypertrophic cardiomyopathy (ApHCM) is a variant of hypertrophic cardiomyopathy characterized by hypertrophy predominantly affecting the apex of the left ventricle.
  • Understanding the phenotypic spectrum and clinical implications of ApHCM subtypes is essential for patient management and risk stratification.

Purpose of the Study:

  • To define the phenotypic spectrum of apical hypertrophic cardiomyopathy (ApHCM).
  • To identify clinical characteristics associated with different ApHCM subtypes.
  • To investigate the predictive value of ApHCM subtyping for clinical outcomes.

Main Methods:

  • 182 consecutive ApHCM patients with preserved ejection fraction (>50%) were analyzed.
  • Left ventricular end-diastolic wall thickness was measured in all 16 segments to classify hypertrophy patterns.
  • Echo-Doppler parameters, electrocardiography, and clinical findings were assessed to correlate with hypertrophy subtypes.

Main Results:

  • Three ApHCM subtypes were identified: pure focal (n=81), pure diffuse (n=70), and mixed (n=31).
  • Significant differences were observed in atrial fibrillation incidence (5% vs. 11% vs. 23%, p<0.05) and left atrial volume index (30.9 vs. 35.7 vs. 41.3 ml/m², p<0.001) among subtypes.
  • Subtypes also showed significant variations in peak systolic and diastolic mitral annular velocities and E/E' ratios (p<0.05).

Conclusions:

  • ApHCM encompasses three morphologically distinct phenotypes.
  • Detailed subtyping of ApHCM is important for predicting atrial fibrillation development.
  • Subtyping aids in assessing left atrial volume index and left ventricular longitudinal function.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...